Also, in the same study, the addition of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib (OLA) associated with CD70 CAR-T showed an increase in CD8 + infiltration and a better survival rate among tumor-bearing mice [30]. The gene discussed is CD70; the disease is neoplasm.